Perrigo fiscal 1996 sales grow 9%, fueled by OTCs, nutritionals.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO FY 1996 SALES INCREASE 9% BUOYED BY GROWING NUTRITIONALS BUSINESS and rising OTC drug sales, the private-label manufacturer reported Aug. 14. Sales for the fiscal year ended June 30 rose to $778.1 mil., up from $717.1 mil. in FY 1995. However, net profits for fiscal 1996 slumped, falling 10.3% to $39.8 mil